{"name":"Evelo Biosciences","slug":"evelo","ticker":"EVLO","exchange":"NASDAQ","domain":"evelobio.com","description":"Evelo Biosciences is a clinical-stage biotechnology company focused on the development of product candidates that harness the power of the microbiome to treat diseases. The company's lead product candidate, EDP1815, is being developed for the treatment of inflammatory diseases, including atopic dermatitis and ulcerative colitis. Evelo Biosciences has a strong pipeline of product candidates in various stages of development, and its products have shown promising results in clinical trials. The company is well-positioned to capitalize on the growing demand for microbiome-based therapies.","hq":"Cambridge, MA","founded":0,"employees":"","ceo":"Simba Gill","sector":"Clinical-Stage Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$85M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":78554000,"netIncome":-114527000,"cash":47940000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"EDP1815 patent cliff ($0.0B at risk)","drug":"EDP1815","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EDP1815 tablet","genericName":"EDP1815 tablet","slug":"edp1815-tablet","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"EDP1815 tablet","genericName":"EDP1815 tablet","slug":"edp1815-tablet","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Evelo Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Evelo Biosciences reported its fourth quarter and full year 2023 financial results, with a net loss of $43.1 million for the year.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Evelo Biosciences Announces Collaboration with Pfizer to Develop Microbiome-Based Therapies","summary":"Evelo Biosciences announced a collaboration with Pfizer to develop microbiome-based therapies for the treatment of inflammatory diseases.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"trial","headline":"Evelo Biosciences Announces Positive Topline Results from Phase 2a Clinical Trial of EDP1815 in Atopic Dermatitis","summary":"Evelo Biosciences announced positive topline results from a Phase 2a clinical trial of EDP1815 in atopic dermatitis.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5XaWZoWVZ6cmpzNVdiSTYwNW4xMjFWZ1lQMmtUalE3QU9XX2hpYW1wcVE2cjc4V290c3NRaHYtNndtTjY5SWRKXy1DRVVwaW5hZ2J3?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"EVLO Stock Price, News & Analysis - Stock Titan","headline":"EVLO Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5DNXZnTzlnZUhuRmdOZEt5ZTd2ZnFZQlVtbFFXNnFRZzF1c0p6TlpTbG9PTlA5bTlsQ05tUkc2a2hyTlplZGNydTYxMm5BSENXVGVuNkl0eU56NXNnOVhSZWVDYzR1M0RJVTR6bUhNZHNRTmd6OEo5VA?oc=5","date":"2024-07-16","type":"pipeline","source":"The Pharma Letter","summary":"Mark Bodmer takes top job at Nucleome - The Pharma Letter","headline":"Mark Bodmer takes top job at Nucleome","sentiment":"neutral"},{"date":"2024-01-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE1vMm5TUEFGc2dXY2xfQXFBcm5MT01sRGxrQ1VBaHV5UWpCdFhyS1g1NmtJQTl6Qk45SFlkeGxhRTJFRldwSmxaNGZ1cDdBa3dNSjJaci1CMDc?oc=5","date":"2023-12-14","type":"pipeline","source":"TradingView","summary":"EVLO Stock Price and Chart — OTC:EVLO - TradingView","headline":"EVLO Stock Price and Chart — OTC:EVLO","sentiment":"neutral"},{"date":"2023-12-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNa1M5S1dFemNCc251WGZlbjVuWDRPYzZib0tzdTFZR19fVHduMzRmVkx1RnBXZEVVdkFtLWt5ZldSUE9lSXBBS1R1Sm1WY3ExS1Q3akVHeEdkQ2FMTGxOZENPb3gtLThYT1VvRHU1U1hmN1ByS082djg3bV9ua1kwS2JEWTNtSGU2R3dLU29YOVE?oc=5","date":"2023-11-22","type":"pipeline","source":"BioPharma Dive","summary":"Flagship-backed microbiome biotech Evelo to shut down - BioPharma Dive","headline":"Flagship-backed microbiome biotech Evelo to shut down","sentiment":"neutral"},{"date":"2023-11-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2023-11-09","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNZU9WYzk1ZjZCbkYxZmZGWGZkM0t6dHhCanFhYXJHRTVRcGNYTVphX3VnVl94OGZqT3l5bkwwVUNOcDlWTHBxVnh5ZV9LR3hxTThKWVlYS1JxOG1LWnUwVk9NUjlIUmdyVHhqbWUxYU1ocTJHOGdjV2luVmg1Q2gyeUZxblpvMndwUUVYZS0wb2o0enhKWE9fVFFUY1hSSnh4Z2drMTZDd2YwV2ZQZmN3ZmJBS2NwNDczZl9Xc0U2d1Zib25Z?oc=5","date":"2023-08-25","type":"trial","source":"Seeking Alpha","summary":"Evelo Biosciences: May Be Worth A Small Long Position Before Psoriasis Phase 2 Results - Seeking Alpha","headline":"Evelo Biosciences: May Be Worth A Small Long Position Before Psoriasis Phase 2 Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTFBKcTRBZ1lkdEFrXzVJN3JDclNhanpzNUtjbHVKYy1sdTZJUnpUR1cxSmhiZWdQRUV5NlVlY01rZ3RpZUhMb2YtZVJUWVF0bW5wWFRMSFo1R2JRYkU?oc=5","date":"2023-03-29","type":"pipeline","source":"Securities.io","summary":"5 Best Microbiome Companies (March 2026) - Securities.io","headline":"5 Best Microbiome Companies (March 2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQOHZZbU1keVphWkdlUWYxRW1tVjdzTUNvZ2RqWWZLNUlFc0h5LVd2VFlZUEcxSVBUYmljaVZ5aGVsVEtDX0QtQTRlT0xBd2NDVFpsZ2VNQXdVM0FXTGVMdnppZzRFN2tKV1BEQS1paXFzb1QxaUx2WGc5bGlnZDRJVVpmZG1QQlBLU19EZTJXcW1kLUlnaFJZR2pTUm5yYkNWeUdyUHpDUXBkc3hPaDlHN2g0NkEzRTBWUjVKWWo3SWFsY3BLTzFuZ2Y0ekR6WjFOTEhr?oc=5","date":"2022-06-07","type":"pipeline","source":"PharmaLive","summary":"Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer - PharmaLive","headline":"Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB3V1JGU0p4QlduaHdhcVhJTXpUd25nMTdaeDIzZTFRa291ejZfbWxoWmpXQlJ4YjZ6ZldOT3RseFlxYzBRaGVBYU1uRkpZVHltQmQtZVQ2UW9MdnFwYjlKZDhlMVJOVDQ?oc=5","date":"2020-10-12","type":"pipeline","source":"Benzinga","summary":"Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga","headline":"Best Biotech Penny Stocks Right Now • Updated Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE14OEhuM0NvTnJFdVZPZXdsblpWRkN2cUF1VnR3anlCTjNuSHplNEtZWmd3elJKUnVQdGZ2RWExa3BzOWxKSy1PZHJaeU1NQzE4RlE?oc=5","date":"2018-05-19","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Evelo Biosciences, Inc. (EVLO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Evelo Biosciences, Inc. (EVLO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1TbFQwZ3l1N01uR0hCRGhhUnpsOEktcWdLR2xmc0N3bmVMR19xT3dQb0E4ZnJ1ay0ySjZteUdvSlRnLV9LTV9tekZMMnB2MUJtVmc?oc=5","date":"2018-05-19","type":"pipeline","source":"Yahoo Finance UK","summary":"Evelo Biosciences, Inc. (EVLO) stock price, news, quote and history - Yahoo Finance UK","headline":"Evelo Biosciences, Inc. (EVLO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"EDP1815","drugSlug":"edp1815","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Pfizer","Janssen Pharmaceuticals","Gilead Sciences"],"therapeuticFocus":["Inflammatory diseases","Microbiome-based therapies"],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":78554000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-114527000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":47940000,"cashHistory":[],"totalAssets":64441000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}